Effects of Sapropterin on Brain and Cognition in Individuals With Phenylketonuria

Trial Profile

Effects of Sapropterin on Brain and Cognition in Individuals With Phenylketonuria

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Dec 2016

At a glance

  • Drugs Sapropterin (Primary)
  • Indications Phenylketonuria
  • Focus Pharmacodynamics
  • Most Recent Events

    • 09 Dec 2014 Planned End Date changed from 1 Mar 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
    • 09 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 10 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top